-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EEXxE0VqEzAEmuKvDTu4OMNm7As0dqcy4o/FpGW4SdXXk5kNzvhaWsBgx4Kn62Bm z6gYbR6zcZ6uM9s0XfuOMA== 0000930413-08-006688.txt : 20081114 0000930413-08-006688.hdr.sgml : 20081114 20081114151041 ACCESSION NUMBER: 0000930413-08-006688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081113 FILED AS OF DATE: 20081114 DATE AS OF CHANGE: 20081114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SALISBURY ROBERT C CENTRAL INDEX KEY: 0001185468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 081190472 BUSINESS ADDRESS: STREET 1: 865 S W 75TH AVENUE STREET 2: SUITE 100 CITY: PLANTATION STATE: FL ZIP: 33324 BUSINESS PHONE: 9542338746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c55681_ex.xml X0303 4 2008-11-13 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001185468 SALISBURY ROBERT C C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 1 0 0 0 Common Stock 2008-11-13 4 P 0 2873 3.19 A 28034 D Common Stock 2008-11-13 4 P 0 600 3.20 A 28634 D Common Stock 2008-11-13 4 P 0 1897 3.21 A 30531 D Common Stock 2008-11-13 4 P 0 500 3.23 A 31031 D Common Stock 2008-11-13 4 P 0 100 3.24 A 31131 D Common Stock 2008-11-13 4 P 0 4030 3.25 D 35161 D /s/ Craig A. Tooman, Attorney-In-Fact 2008-11-14 -----END PRIVACY-ENHANCED MESSAGE-----